clinicalenzymology-120625130732-phpapp02.pptx

download clinicalenzymology-120625130732-phpapp02.pptx

of 48

Transcript of clinicalenzymology-120625130732-phpapp02.pptx

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    1/48

    Biochemistry for Medics

    www.namrata.co

    10/25/2013 1Biochemistry for Medics

    http://www.namrata.co/http://www.namrata.co/http://www.namrata.co/http://www.namrata.co/http://www.namrata.co/http://www.namrata.co/
  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    2/48

    1) Enzymes can act as diagnosticmarkers of underlying diseases .

    2) Enzymes can also act asreagents for various biochemicalestimations and detections

    10/25/2013 2Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    3/48

    1)Functional plasma enzymes( Plasma derivedenzymes)- Certain enzymes, proenzymes, andtheir substrates are present at all times in thecirculation of normal individuals and perform aphysiologic function in the blood.

    Examples of these functional plasma enzymesinclude lipoprotein lipase, pseudocholinesterase, and the proenzymes of bloodcoagulation and blood clot dissolution .Themajority of these enzymes are synthesized inand secreted by the liver.

    10/25/2013 3Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    4/48

    2) Nonfunctional plasma enzymes (Cell derivedenzymes)-Plasma also contains numerous otherenzymes that perform no known physiologicfunction in blood.

    These apparently nonfunctional plasma enzymesarise from the routine normal destruction oferythrocytes, leukocytes, and other cells.

    10/25/2013 4Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    5/48

    Tissue damage or necrosis resulting from

    injury or disease is generally accompanied byincreases in the levels of severalnonfunctional plasma enzymes.

    10/25/2013 5Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    6/48

    A) Increased releasei. Necrosis of cellii. Increased permeability of cell without grosscellular damageiii. Increased production of enzyme within the cellresulting in increase in serum by overflowiv. Increase in tissue source of enzyme as inmalignancy

    B) Impaired dispositioni. Increased levels in obstructive jaundiceii. Increased levels in renal failure

    10/25/2013 6Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    7/48

    A. Decreased formation which may bei. Geneticii. Acquired

    B. Enzyme inhibitionC. Lack of cofactors

    10/25/2013 7Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    8/48

    International unit One IU is defined as the activity ofthe enzyme which transforms one micro mole ofsubstrate in to products per minute per litre of sampleunder optimal conditions and at defined temperature .It is expressed as IU/LKatal catalytic unit One Katal is defined as thenumber of mole of substrate transformed per secondper litre of sample. It is abbreviated as kat or k.60 U=mkat and 1nkat=0.06U

    10/25/2013 8Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    9/48

    Single or serial assay of serum activity of a selectedenzyme-1) Helps in making the diagnosis/differential

    diagnosis/ early detection of a disease

    2) Helps in ascertaining prognosis of a disease3) Helps in ascertaining the response to drugs in a

    disease4) Also help in ascertaining the time course of

    disease.

    10/25/2013 9Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    10/48

    Enzyme estimations are helpful in the diagnosisof1) Myocardial Infarction

    2) Liver diseases3) Muscle diseases4) Bone diseases5) Cancers6) GI Tract diseases

    10/25/2013 10Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    11/48

    The diagnosis of AMI is usually predicated on theWHO criteria ofchest pain, ECG changes, andincreases in biochemical markers of myocardialinjury.

    Half of the patients with "typical" symptoms donot have AMI.

    The ECG is specific for AMI, but lacks sensitivity.

    In contrast, biochemical markers have excellent

    sensitivity for diagnosing AMI. By combining themost sensitive and the most specific tests,diagnostic accuracy can be enhanced.

    10/25/2013 11Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    12/48

    Enzyme assays routinely carried out for the

    diagnosis of Acute Myocardial Infarction are-

    1)Creatine Phospho kinase,2) Aspartate transaminase and3) Lactate dehydrogenaseAcceptable biochemical markers of ischemic

    heart disease are now considered to includemyoglobin, CK-MB, total CK, and cardiactroponins T and I.

    Serum enzymes in AcuteMyocardial Infarction

    10/25/2013 12Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    13/48

    It is an enzyme found primarily in the heartand skeletal muscles, and to a lesser extentin the brain but not found at all in liver andkidney

    Catalyzes the transfer of phosphate betweencreatine and ATP/ADPProvides rapid regeneration of ATP when ATPis lowCreatine phosphate is regenerated when ATPis abundant

    10/25/2013 13Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    14/48

    After myocardial infarction- serum value is foundto increase within 3-6 hours, reaches a peak levelin 24- 30 hours and returns to normal level in 2-4days (usually in 72 hours).

    Normal Value- serum activity varies from 10-50IU/L at 30C.CK is a sensitive indicator in the early stages ofmyocardial ischemia.

    No increase in activity is found in heart failure and

    coronary insufficiency.In acute MI, CPK usually rises faster than SGOTand returns to normal faster than the SGOT.

    10/25/2013 14Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    15/48

    There are three Isoenzymes.Measuring them is of value in the presenceof elevated levels of CK or CPK to determinethe source of the elevation.Each iso enzyme is a dimer composed of two

    protomers M (for muscles) and B( forBrain).These isoenzymes can be separated by,Electrophoresis or by Ion exchange

    Chromatography.

    CK/CPK Isoenzymes

    10/25/2013 15Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    16/48

    Isoenzyme Electrophoretic mobility Tissue oforigin Meanpercentage inbloodMM(CK3) Least Skeletal

    muscleHeart muscle

    97-100%

    MB(CK2) Intermediate Heart muscle 0-3%

    BB(CK1) Maximum Brain 0%

    10/25/2013 16Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    17/48

    Normal levels of CK/CPK are almost entirely MM,from skeletal muscle.Elevated levels of CK/CPK resulting from acutemyocardial infarction are about half MM and half MB.Myocardial muscle is the only tissue that contains

    more than five percent of the total CK activity as theCK2 (MB) isoenzyme.Following an attack of acute myocardial infarction,this isoenzyme appears within 4 hours followingonset of chest pain, reaches a peak of activity atapproximately 24 hours and falls rapidly. MB accounts for 4.5- 20 % of the total CK activity inthe plasma of the patients with recent myocardialinfarction and the total isoenzyme is elevated up to20-folds above the normal.

    10/25/2013 17Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    18/48

    It is also called as Serum Glutamate Oxalo

    acetate Transaminase (SGOT).The level is significantly elevated in AcuteMI.

    Normal Value- 0-41 IU/L at 37CIn acute MI- Serum activity rises sharplywithin the first 12 hours, with a peak level at24 hours or over and returns to normal

    within 3-5 days.The rise depends on the extent of infarction.Re- infarction results in secondary rise ofSGOT.

    10/25/2013 18Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    19/48

    Prognostic significance- Levels> 350 IU/L aredue to massive infarction (Fatal), > 150 IU/L areassociated with high mortality and levels < 50IU/L are associated with low mortality.

    Other diseases- The rise in activity is alsoobserved in muscle and hepatic diseases. Thesecan be well differentiated from simultaneousestimations of other enzyme activities like SGPTetc, which do not show and rise in activity inAcute MI.

    10/25/2013 19Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    20/48

    Lactate dehydrogenase catalyzes thereversible conversion of pyruvate and lactate.

    Normal level- 55-140 IU/L at 30C. Thelevels in the upper range are generally seen

    in children.LDH level is 100 times more inside the RBCsthan in plasma, and therefore minor amountof hemolysis results in false positive result.

    10/25/2013 20Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    21/48

    In Acute MI-The serum activity rises within12 to 24 hours, attains a peak at 48 hours (2to 4 days) reaching about 1000 IU/L and thenreturns gradually to normal from 8 th to 14th day.

    The magnitude of rise is proportional to theextent of myocardial infarction.

    Serum LDH elevation may persist for more

    than a week after CPK and SGOT levels havereturned to normal levels.

    10/25/2013 21Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    22/48

    Other diseases-The increase in serum activityof LDH is also seen in hemolytic anemias,hepatocellular damage, musculardystrophies, carcinoma, Leukemias, and any

    condition which causes necrosis of the bodycells.

    Since the total LDH is increased in manydiseases, so the study of Iso enzymes of LDH

    is of more significance.

    10/25/2013 22Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    23/48

    LDH enzyme is tetramer with 4 subunits.The subunit may be either H(Heart) or M(Muscle)polypeptide chains.

    These two chains are the product of 2 differentgenes.

    Although both of them have the same molecularweight, there are minor amino acid variations.

    There can be 5 possible combinations; H4,H3M1, H2M2, H1M3. M4, these are 5 different

    types of isoenzymes seen in all individuals.

    10/25/2013 23Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    24/48

    10/25/2013 24Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    25/48

    No. of

    Isoenzyme Subunitmake up ofisoenzyme

    Electrophore

    tic mobility

    at pH8.6

    Activity at

    60for 30

    minutes

    Tissue origin Percentagein human

    serum(Mean)LDH-1 H4 Fastest Not

    destroyed Heartmuscle 30%LDH-2 H3M1 Faster Not

    destroyed. RBC 35%LDH-3 H2M2 Fast Partly

    destroyed Brain 20%LDH-4 H1M3 Slow Destroyed Liver 10%LDH-5 M4 Slowest Destroyed Skeletal

    Muscles5%

    Normally LDH- 2(H3M1) level in blood is greater than LDH-1, butthis pattern is reversed in myocardial infarction, this is calledflipped pattern.

    10/25/2013 25Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    26/48

    They are not enzymes; however they are accepted asmarkers of myocardial infarction.The Troponin complex consists of 3 components;Troponin C (Calcium binding), Troponin I(ActomyosinATPase inhibitory element), and Troponin T(Tropomyosinbinding element).Troponin I is released in to the circulation within 4 hoursof the onset of cardiac manifestations, peak is observed at14-24 hours and remains elevated for 3-5 days postinfarction.Serum level ofTnT increases within 6 hous of myocardialinfarction, peaks at 72 hours and then remains elevatedup to 7-10 days. The TnT2 estimation is 100% sensitiveindex for myocardial infarction.

    10/25/2013 26Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    27/48

    One of earliest markers is myoglobin, whichis very sensitive but, in certain clinicalsettings, lacks specificity.

    Its level rises within 4 hours of infarctionFalsely high levels may be observed inpatients of Renal failure or patients havingmuscle injuries.

    10/25/2013 27Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    28/48

    10/25/2013 28Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    29/48

    Serum enzyme tests can be grouped into twocategories:

    (1) enzymes whose elevation in serumreflects damage to hepatocytes

    (2) enzymes whose elevation in serumreflects cholestasis.

    10/25/2013 29Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    30/48

    The aminotransferases (transaminases) aresensitive indicators of liver cell injury and aremost helpful in recognizing acute

    hepatocellular diseases such as hepatitis.These include-

    1) Aspartate aminotransferase (AST) and

    2) Alanine aminotransferase (ALT).

    10/25/2013 30Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    31/48

    AST is found in the liver, cardiac muscle,skeletal muscle, kidneys, brain, pancreas,lungs, leukocytes, and erythrocytes indecreasing order of concentration.Normal level- 0-41 IU/LALT is found primarily in the liver.Normal level-0-45 IU/LThe aminotransferases are normally presentin the serum in low concentrations. Theseenzymes are released into the blood ingreater amounts when there is damage to theliver cell membrane resulting in increasedpermeability.

    10/25/2013 31Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    32/48

    Levels of up to 300 U/L are nonspecific and may be found inany type of liver disorder.Striking elevationsi.e., aminotransferases > 1000 U/Loccur almost exclusively in disorders associated withextensive hepatocellular injury such as (1) viral hepatitis, (2)ischemic liver injury (prolonged hypotension or acute heartfailure), or (3) toxin- or drug-induced liver injury.In most acute hepatocellular disorders, the ALT is higher thanor equal to the AST.

    An AST:ALT ratio > 2:1 is suggestive while a ratio > 3:1 ishighly suggestive of alcoholic liver disease.The AST in alcoholic liver disease is rarely >300 U/L and theALT is often normal.

    A low level of ALT in the serum is due to an alcohol-induceddeficiency of Pyridoxal phosphate.

    In obstructive jaundice the aminotransferases are usually not10/25/2013 32Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    33/48

    The activities of three enzymes

    1)Alkaline phosphatase,2) 5'-nucleotidase, and3) -Glutamyl transpeptidase (GGT)are usuallyelevated in cholestasis.Alkaline phosphatase and 5'-nucleotidase arefound in or near the bile canalicular membraneof hepatocytes, while GGT is located in theendoplasmic reticulum and in bile duct epithelialcells.

    10/25/2013 33Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    34/48

    The normal serum alkaline phosphatase consists of many

    distinct isoenzymes found in the liver, bone, placenta,and, less commonly, small intestine.Physiological Variations-Patients over age 60 can have a mildly elevated alkalinephosphatase.Individuals with blood types O and B can have anelevation of the serum alkaline phosphatase after eating afatty meal due to the influx of intestinal alkalinephosphatase into the blood.It is also nonpathologically elevated in children andadolescents undergoing rapid bone growth, because of

    bone alkaline phosphatase.

    It is also high late in normal pregnancy due to the influxof placental alkaline phosphatase.

    10/25/2013 34Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    35/48

    Pathological variations-Elevation of liver-derived alkalinephosphatase is not totally specific forcholestasis, and a less than threefold

    elevation can be seen in almost any type ofliver disease.

    Alkaline phosphatase elevations greater thanfour times normal occur primarily in patientswith cholestatic liver disorders, infiltrativeliver diseases such as cancer andamyloidosis.

    10/25/2013 35Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    36/48

    In liver diseases, the elevation is almost always due to increased

    amounts of the liver isoenzyme.

    In the absence of jaundice or elevated aminotransferases, anelevated alkaline phosphatase of liver origin often, but not always,suggests early cholestasis and, less often, hepatic infiltration bytumor or granulomata.Intrahepatic cholestasis- Values are increased in drug-inducedhepatitis, primary biliary cirrhosis, rejection of transplanted liver,and, rarely, alcohol-induced steatonecrosis.

    Extrahepatic cholestasis- Very high values are found inobstructive jaundice due to cancer, common duct stone, sclerosingcholangitis, or bile duct stricture

    The level of serum alkaline phosphatase elevation is not helpful indistinguishing between intrahepatic and extrahepatic cholestasis.

    10/25/2013 36Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    37/48

    1. Hepatic Isoenzyme Travels fastest towardsthe anode and occupies the same position asAlpha 2 globulin. Its level rises in extrahepatic biliary obstruction.

    2. Bone Isoenzyme-Increases die to osteoblasticactivity and is normally elevated in childrenduring periods of active growth .

    3. Placental Isoenzyme - Rises during last 6weeks of pregnancy.

    4. Intestinal Isoenzyme- Rise occurs after a fattymeal. May increase during various GIdisorders.

    10/25/2013 37Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    38/48

    Regan isoenzyme Present in plasma of about 15% of patients withcarcinoma of lung, liver or gutAlso seen in chronic smokersStructurally resembles placental ALPNagao IsoenzymeVariant of Regan isoenzymeDetected in metastatic carcinoma of pleural surfacesand adenocarcinoma of pancreas and bile duct.

    10/25/2013 38Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    39/48

    It is involved in amino acid transport across themembranes.Found mainly in biliary ducts of the liver, kidneyand pancreas.Enzyme activity is induced by a number of drugsand in particular alcohol.-GT increased in liver diseases especially inobstructive jaundice.-GT levels are used as a marker of alcoholinduced liver disease and in liver cirrhosis.

    10/25/2013 39Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    40/48

    Moderately increased in hepatitis and highlyelevated in biliary obstruction.

    Unlike ALP the level is unrelated toosteoblastic activity and is thus unaffected by

    bone disease. The enzyme hydrolyses 5 nucleotides to 5

    nucleosides at an optimum p H of7.5

    10/25/2013 40Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    41/48

    In viral hepatitisRapid rise intransaminases (AST& ALT) in serum

    occurs even beforebilirubin rise is seen

    10/25/2013 41Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    42/48

    1) Alkaline Phosphatase-Rises in Rickets,osteomalacia, hyperparathyroidism and inPagets disease. Also rises in primary andsecondary malignancies of bones.

    2) Acid Phosphatase-Highly increased inbony metastasis of carcinoma prostate

    10/25/2013 42Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    43/48

    1. Aspartate Transferase- Not commonlydone

    2. Aldolase-Moderate increase inDermatomyositis, muscular dystrophies,highest values are seen in Deuchenne type

    of muscular dystrophies3. CPK- Elevated in neurogenic musculardystrophies, highest values are seen inDeuchenne type of muscular dystrophies

    10/25/2013 43Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    44/48

    Amylase-Serum activity > 1000 units is seenwithin 24 hours in acute Pancreatitis, valuesare diagnostic. A raised serum activity is alsoseen in perforated peptic ulcer and intestinal

    obstruction. Lipase-Levels as high as 2800 U/l are seen in

    acute pancreatitis. Also reported high inperforated duodenal and peptic ulcers andintestinal obstruction.

    10/25/2013 44Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    45/48

    Enzyme DiseaseSerum acid phosphatase Cancer prostate

    Serum Alkaline phosphatase Metastasis in liver, jaundice due tocarcinoma head of pancreas,osteoblastic metastasis in bones

    Serum LDH Advanced malignancies andLeukemias

    - Glucuronidase Cancer of urinary bladder

    Leucine Amino Peptidase (LAP) Liver cell carcinoma

    Neuron specific Enolase Malignancies of nervous tissue and

    brain

    10/25/2013 45Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    46/48

    Enzyme Used for testingUrease Urea

    Uricase Uric acid

    Glucose oxidase Glucose

    Cholesterol oxidase Cholesterol

    Lipase Triglycerides

    Alkaline phosphatase ELISA

    Horse radish Peroxidase ELISA

    Restriction endonuclease Recombinant DNA technology

    Reverse transcriptase Polymerase chain reaction

    10/25/2013 46Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    47/48

    Enzyme Therapeutic ApplicationStreptokinase/Urokinase Acute MI, Pulmonary embolism,

    DVT(Deep vein thrombosis)

    Trypsin, lipase and amylase Pancreatic insufficiency

    Asparaginase/Glutaminase Acute lymphoblastic leukemias

    Hyaluronidase Enhanced local anesthesia and foreasy diffusion of fluids

    Papain Anti inflammatory

    Chymotrypsin Pain killer and Anti inflammatory

    Alpha- 1 Antitrypsin Deficiency and Emphysema

    Serratopeptidase Pain killer and Anti inflammatory

    10/25/2013 47Biochemistry for Medics

  • 7/27/2019 clinicalenzymology-120625130732-phpapp02.pptx

    48/48

    NAME OF THE ENZYME Conditions in which level of activityin serum is elevated

    Aspartate Amino transferase (AST)

    Serum glutamate-oxaloacetate

    transaminase (SGOT)

    Myocardial infarction, Liver disease

    especially with liver cell damage

    Alanine Amino transferase (ALT)Serum glutamate-pyruvate

    transaminase (SGPT)

    Liver disease especially with liver celldamage

    Alkaline Phosphatase (ALP) Liver disease- biliary obstruction

    Osteoblastic bone disease-rickets

    Acid Phosphatase (ACP) Prostatic carcinoma

    glutamyl Transferase ( GT) Liver disorder like liver cirrhosis and

    alcoholism

    Creatine kinase (CK) Myocardial infarction and skeletal

    muscle disease(muscular dystrophy